<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04888494</url>
  </required_header>
  <id_info>
    <org_study_id>STU00211858</org_study_id>
    <secondary_id>5P50DA044121</secondary_id>
    <nct_id>NCT04888494</nct_id>
  </id_info>
  <brief_title>Hippocampal Stimulation in Chronic Low Back Pain</brief_title>
  <official_title>Enhancing Cortical-hippocampal Functional Connectivity as a Novel Means for Relieving Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators aim to examine the effects of Transcranial Magnetic&#xD;
      Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with&#xD;
      chronic low back pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants will receive the 2 modalities of stimulation (hippocampal and sham-TMS). Each stimulation round is composed by 5 daily sessions of stimulation, participants will not know which round is active and which is sham. The order of the stimulation modalities will be different across subjects. Subjects will be randomly assigned to one of two possible modality order according to the entrance in the study.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Hippocampal connectivity</measure>
    <time_frame>approximately 6 weeks - Baseline and after the end of hippocampal stimulation</time_frame>
    <description>Changes in hippocampal network connectivity will be evaluated by using resting state functional magnetic resonance (fMRI) before and after hippocampal stimulation. Hippocampal connectivity measurements - regions involved in the network and the parietal target - will be compared before stimulation (baseline) to after stimulation (after active hippocampal stimulation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in pain scales</measure>
    <time_frame>1, 2 , 4 and 6 weeks</time_frame>
    <description>The end point will be severity of pain measured by changes in chronic back pain as indexed by a Numeric rating Scale (NRS) before and after each stimulation round.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Back Pain</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Hippocampus-stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active high-frequency rTMS (20 Hz pulse trains)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sham rTMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>For the brain stimulation the investigators will use Repetitive Transcranial Magnetic stimulation (rTMS). Different stimulation conditions (hippocampal or sham) will be delivered in each round of stimulation (5 days). Repetitive TMS will be applied at 100% resting motor threshold intensity, 20 Hz pulse trains separated by 28-s inter-train intervals (~20 minutes for the entire daily stimulation session). Stimulation parameters will be identical in both groups</description>
    <arm_group_label>Hippocampus-stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS</intervention_name>
    <description>Sham rTMS</description>
    <arm_group_label>Sham-stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 6 months of back pain on a daily basis;&#xD;
&#xD;
          -  male or female with no racial or ethnic restrictions;&#xD;
&#xD;
          -  18 to 75 years old;&#xD;
&#xD;
          -  average back pain intensity &gt; 4/10 at study entry;&#xD;
&#xD;
          -  must be able to read, understand, and sign consent form;&#xD;
&#xD;
          -  generally healthy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  back pain with fever, chills, rheumatoid arthritis, ankylosing spondylitis, acute&#xD;
             vertebral fractures,&#xD;
&#xD;
          -  history of tumor in the back;&#xD;
&#xD;
          -  back surgery within the past 6 months;&#xD;
&#xD;
          -  Chronic neurologic conditions, e.g., Parkinson's&#xD;
&#xD;
          -  involvement in litigation regarding back pain;&#xD;
&#xD;
          -  other severe medical diseases;&#xD;
&#xD;
          -  pregnancy;&#xD;
&#xD;
          -  positive urinary screen for any recreational drugs,&#xD;
&#xD;
          -  opioids use;&#xD;
&#xD;
          -  use of anticoagulants (low dose ASA allowed);&#xD;
&#xD;
          -  history of gastric ulcer; renal insufficiency or congestive heart failure,&#xD;
&#xD;
          -  contraindication to MRI,&#xD;
&#xD;
          -  contraindication to TMS; including history of seizure/epilepsy*&#xD;
&#xD;
          -  Any medical condition that in the investigator's judgment may prevent the individual&#xD;
             from completing the study or put the individual at undue risk;&#xD;
&#xD;
          -  In the judgment of the investigator, unable or unwilling to follow protocol and&#xD;
             instructions;&#xD;
&#xD;
          -  Diagnosis of major depression;&#xD;
&#xD;
          -  Intra-axial implants (e.g. spinal cord stimulators or pumps)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Camila Bonin Pinto, PhD</last_name>
    <phone>3125033971</phone>
    <email>camila.pinto@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Perez</last_name>
    <phone>3125033971</phone>
    <email>jennifer.perez@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camila Pinto</last_name>
      <phone>312-503-3971</phone>
      <email>camila.pinto@northwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Perez</last_name>
      <phone>(312) 975 0594</phone>
      <email>jennifer.perez@northwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Apkar Apkarian, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 12, 2021</study_first_submitted>
  <study_first_submitted_qc>May 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Apkar Apkarian</investigator_full_name>
    <investigator_title>Director Center for Translational Pain Research, Director Center of Excellence for Chronic Pain and Drug Abuse Research, Professor of Physiology, Anesthesia, PM&amp;R Northwestern University, Feinberg School of Medicine</investigator_title>
  </responsible_party>
  <keyword>transcranial magnetic stimulation</keyword>
  <keyword>resting state MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Documents will be provided by Apkar Apkarian</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

